INSIGHTS ON CLINICAL TRIAL PARTNERING

• Building Bioanalysis Infrastructure For Modern Drug Development

  Drug development accelerates with AI, decentralized trials, and adaptive protocols, but legacy CRO infrastructure lags. Platform-based systems enable speed, quality, automation, and continuous improvement.

• Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs

  Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.

• The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials

  Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.

• Key Criteria For Choosing The Right Phase 1 CRO

  What steps can you take to select the best CRO partner for your Phase 1 clinical trial?

• Expedite Drug Development With An Integrated CDMO-CRO Model

  2/6/2026

  From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.

• How RFI/RFP Optimization Changes The Game

  8/22/2025

  Selecting the right vendors can determine whether a clinical trial advances smoothly or stalls under budget overruns and delays.

• Global Vaccine Trials Case Study

  5/22/2024

  Explore targeted strategies for tackling the complexities of international payments and providing comprehensive participant support in global vaccine trials.

• 8 Critical Questions To Ask Your IRB

  2/5/2025

  This article outlines eight essential questions to ask a potential IRB partner to assess their ability to help you navigate complex regulatory requirements while avoiding delays.

• Delivering Specialist Neurology Support

  4/17/2025

  Explore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.